Pf332

Pf332 (PF3D7_1149000) is a megadalton, glutamic acid-rich exported protein of blood-stage Plasmodium falciparum that acts as a scaffolding/anchoring protein at the infected erythrocyte, maintaining Maurer's cleft morphology, modulating red cell rigidity, and supporting surface display of the cytoadherence ligand PfEMP1 (PMID:1544579, PMID:18832660). It is trafficked from the parasite through a Brefeldin A-sensitive classical Golgi pathway and delivered to the erythrocyte via large vesicle-like structures associated with Maurer's clefts, reaching the erythrocyte surface only at very late stages of development (PMID:7957750). Within the erythrocyte cytoplasm Pf332 occupies the core of large multimeric vesicle assemblies that co-carry PfEMP1 and RIFIN at their outer rim, placing it in a shared trafficking route for surface variant antigens (PMID:14668007). Genetic deletion increases RBC rigidity, reduces CD36 adhesion, lowers surface PfEMP1, and distorts Maurer's clefts, while truncation restores adhesion and cleft morphology but not rigidity, indicating that distinct regions of the protein govern these functions (PMID:18832660). Its DBL-like domain adopts a canonical DBL fold, but loss-of-function shows no role in cytoadhesion or merozoite invasion, arguing against a direct receptor-ligand function (PMID:19007413). Pf332 enters the secretory pathway through an internal, non-cleaved hydrophobic sequence whose termini both enter the ER lumen to form a productive lumenal export intermediate (PMID:37000891).

1. 1992 Medium

   Establishing that Pf332 is a giant glutamic acid-rich protein exported into the infected erythrocyte defined it as a candidate host-cell-remodeling antigen rather than an intracellular parasite protein.

   Evidence Western blot, immunoprecipitation, immunofluorescence and sequence mapping of a ~20 kb chromosome 11 gene in P. falciparum

   PMID:1544579

   Open questions at the time

   • Function of the protein at the erythrocyte membrane not tested
   • Trafficking route not resolved
2. 1994 High

   Defining the export route showed Pf332 uses a classical Golgi-dependent secretory pathway and transits via Maurer's clefts, situating it in the parasite's protein-export machinery.

   Evidence Monoclonal antibody IFA, immunoelectron microscopy, Brefeldin A block and developmental time-course in P. falciparum

   PMID:7957750

   Open questions at the time

   • Molecular signal driving ER entry not identified
   • Cargo relationship to other exported proteins unresolved
3. 2003 Medium

   Co-localization with PfEMP1, PfExp-1 and PfSbp1 across a continuous erythrocyte membrane network implicated Pf332 in trafficking of surface-destined proteins.

   Evidence Antibody co-localization by light and electron microscopy plus vital staining in P. falciparum

   PMID:12868595

   Open questions at the time

   • Functional consequence inferred, not tested for Pf332
   • Direct physical interactions not demonstrated
4. 2004 Medium

   Mapping Pf332 to the core of large multimeric vesicles with PfEMP1 and RIFIN at the rim refined its position within a common variant-antigen trafficking pathway.

   Evidence Co-localization immunofluorescence and BODIPY-ceramide staining in P. falciparum strain 3D7

   PMID:14668007

   Open questions at the time

   • Sub-compartmentalization not functionally validated for Pf332
   • Mechanism of core targeting unknown
5. 2008 High

   Genetic deletion and truncation established causal roles for Pf332 in maintaining Maurer's cleft morphology, controlling RBC rigidity, and enabling PfEMP1 surface display and CD36 adhesion, and showed these functions map to separable regions of the protein.

   Evidence Transgenic deletion/truncation with micropipette aspiration, CD36 adhesion assay, surface-PfEMP1 flow cytometry and EM of Maurer's clefts in P. falciparum

   PMID:18832660

   Open questions at the time

   • Molecular partners mediating cleft maintenance not identified
   • Mechanism linking Pf332 to rigidity unresolved
6. 2008 High

   Biochemical validation of the DBL-like fold combined with loss-of-function assays reclassified Pf332 as a scaffolding/anchoring protein rather than a cytoadherence ligand.

   Evidence Recombinant expression, disulfide-bond analysis, structural modeling and transgenic deletion/truncation with cytoadhesion, invasion and deformability assays in P. falciparum

   PMID:19007413

   Open questions at the time

   • Adhesion phenotype partially contradicts PMID:18832660
   • Native binding partner of the DBL-like domain unknown
7. 2023 Medium

   Defining the ER-targeting mechanism revealed that Pf332 relies on an internal, non-cleaved hydrophobic sequence that forms a lumenal intermediate, explaining how this signal-peptide-less giant protein enters the export pathway.

   Evidence Intact-cell topology assays, KDEL-retention tagging, protease protection and fractionation in P. falciparum

   PMID:37000891

   Open questions at the time

   • Downstream translocation steps from ER not mapped
   • Single-lab finding of the lumenal intermediate

• The direct molecular partners through which Pf332 anchors Maurer's clefts and modulates erythrocyte rigidity remain unidentified.
• No biochemically defined interactome for Pf332
• Mechanism connecting the DBL-like domain to scaffolding function unknown